US Stock MarketDetailed Quotes

ACUR Acura Pharmaceuticals Inc

Watchlist
  • 0.002301
  • 0.0000000.00%
15min DelayClose Nov 26 16:00 ET
151.87KMarket Cap-115P/E (TTM)

Acura Pharmaceuticals Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
Total revenue
-56.22%1.56M
-94.99%36K
-34.15%270K
-54.63%613K
-40.97%644K
34.36%3.57M
-41.15%718K
-69.03%410K
2,836.96%1.35M
1,528.36%1.09M
Operating revenue
-56.22%1.56M
-94.99%36K
-34.15%270K
-54.63%613K
-40.97%644K
34.36%3.57M
-41.15%718K
-69.03%410K
2,836.96%1.35M
1,528.36%1.09M
Cost of revenue
Gross profit
Operating expense
-35.84%2.78M
-67.84%273K
-17.85%801K
-1.83%913K
-49.81%790K
27.97%4.33M
-10.73%849K
-3.75%975K
39.22%930K
109.87%1.57M
Selling and administrative expenses
-50.80%1.25M
-116.95%-71K
-8.77%416K
7.84%523K
-67.57%385K
35.70%2.55M
-13.79%419K
-16.79%456K
19.46%485K
171.62%1.19M
-General and administrative expense
-50.80%1.25M
-116.95%-71K
-8.77%416K
7.84%523K
-67.57%385K
35.70%2.55M
-13.79%419K
-16.79%456K
19.46%485K
171.62%1.19M
Research and development costs
-14.43%1.52M
-20.00%344K
-25.82%385K
-12.36%390K
4.65%405K
18.34%1.78M
-7.53%430K
11.61%519K
69.85%445K
23.64%387K
Operating profit
-60.16%-1.21M
-80.92%-237K
6.02%-531K
-171.26%-300K
69.77%-146K
-4.55%-758K
-148.70%-131K
-281.67%-565K
167.68%421K
29.28%-483K
Net non-operating interest income expense
55.56%-200K
0
0
23.01%-87K
-0.89%-113K
-0.22%-450K
1.75%-112K
-1.80%-113K
5.04%-113K
-6.67%-112K
Non-operating interest expense
-55.56%200K
--0
--0
-23.01%87K
0.89%113K
-2.60%450K
-1.75%112K
1.80%113K
-8.13%113K
-1.75%112K
Other net income (expense)
535K
266K
269K
Special income (charges)
--535K
--266K
--269K
----
----
--0
--0
--0
----
----
-Less:Other special charges
---535K
---266K
---269K
----
----
----
----
----
----
----
Income before tax
27.24%-879K
111.93%29K
61.36%-262K
-225.65%-387K
56.47%-259K
67.99%-1.21M
-256.77%-243K
-439.00%-678K
109.22%308K
24.49%-595K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
27.24%-879K
111.93%29K
61.36%-262K
-225.65%-387K
56.47%-259K
67.99%-1.21M
-256.77%-243K
-439.00%-678K
109.22%308K
24.49%-595K
Net income continuous Operations
27.24%-879K
111.93%29K
61.36%-262K
-225.65%-387K
56.47%-259K
67.99%-1.21M
-256.77%-243K
-439.00%-678K
109.22%308K
24.49%-595K
Minority interest income
Net income attributable to the parent company
27.24%-879K
111.93%29K
61.36%-262K
-225.65%-387K
56.47%-259K
67.99%-1.21M
-256.77%-243K
-439.00%-678K
109.22%308K
24.49%-595K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.24%-879K
111.93%29K
61.36%-262K
-225.65%-387K
56.47%-259K
67.99%-1.21M
-256.77%-243K
-439.00%-678K
109.22%308K
24.49%-595K
Basic earnings per share
50.00%-0.02
103.84%0.0004
82.67%-0.0035
-200.00%-0.01
50.00%-0.01
71.43%-0.04
-304.88%-0.01
-415.91%-0.02
106.67%0.01
50.00%-0.02
Diluted earnings per share
50.00%-0.02
103.84%0.0004
82.67%-0.0035
-200.00%-0.01
50.00%-0.01
71.43%-0.04
-304.88%-0.01
-415.91%-0.02
106.67%0.01
50.00%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020
Total revenue -56.22%1.56M-94.99%36K-34.15%270K-54.63%613K-40.97%644K34.36%3.57M-41.15%718K-69.03%410K2,836.96%1.35M1,528.36%1.09M
Operating revenue -56.22%1.56M-94.99%36K-34.15%270K-54.63%613K-40.97%644K34.36%3.57M-41.15%718K-69.03%410K2,836.96%1.35M1,528.36%1.09M
Cost of revenue
Gross profit
Operating expense -35.84%2.78M-67.84%273K-17.85%801K-1.83%913K-49.81%790K27.97%4.33M-10.73%849K-3.75%975K39.22%930K109.87%1.57M
Selling and administrative expenses -50.80%1.25M-116.95%-71K-8.77%416K7.84%523K-67.57%385K35.70%2.55M-13.79%419K-16.79%456K19.46%485K171.62%1.19M
-General and administrative expense -50.80%1.25M-116.95%-71K-8.77%416K7.84%523K-67.57%385K35.70%2.55M-13.79%419K-16.79%456K19.46%485K171.62%1.19M
Research and development costs -14.43%1.52M-20.00%344K-25.82%385K-12.36%390K4.65%405K18.34%1.78M-7.53%430K11.61%519K69.85%445K23.64%387K
Operating profit -60.16%-1.21M-80.92%-237K6.02%-531K-171.26%-300K69.77%-146K-4.55%-758K-148.70%-131K-281.67%-565K167.68%421K29.28%-483K
Net non-operating interest income expense 55.56%-200K0023.01%-87K-0.89%-113K-0.22%-450K1.75%-112K-1.80%-113K5.04%-113K-6.67%-112K
Non-operating interest expense -55.56%200K--0--0-23.01%87K0.89%113K-2.60%450K-1.75%112K1.80%113K-8.13%113K-1.75%112K
Other net income (expense) 535K266K269K
Special income (charges) --535K--266K--269K----------0--0--0--------
-Less:Other special charges ---535K---266K---269K----------------------------
Income before tax 27.24%-879K111.93%29K61.36%-262K-225.65%-387K56.47%-259K67.99%-1.21M-256.77%-243K-439.00%-678K109.22%308K24.49%-595K
Income tax 0000000000
Net income 27.24%-879K111.93%29K61.36%-262K-225.65%-387K56.47%-259K67.99%-1.21M-256.77%-243K-439.00%-678K109.22%308K24.49%-595K
Net income continuous Operations 27.24%-879K111.93%29K61.36%-262K-225.65%-387K56.47%-259K67.99%-1.21M-256.77%-243K-439.00%-678K109.22%308K24.49%-595K
Minority interest income
Net income attributable to the parent company 27.24%-879K111.93%29K61.36%-262K-225.65%-387K56.47%-259K67.99%-1.21M-256.77%-243K-439.00%-678K109.22%308K24.49%-595K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.24%-879K111.93%29K61.36%-262K-225.65%-387K56.47%-259K67.99%-1.21M-256.77%-243K-439.00%-678K109.22%308K24.49%-595K
Basic earnings per share 50.00%-0.02103.84%0.000482.67%-0.0035-200.00%-0.0150.00%-0.0171.43%-0.04-304.88%-0.01-415.91%-0.02106.67%0.0150.00%-0.02
Diluted earnings per share 50.00%-0.02103.84%0.000482.67%-0.0035-200.00%-0.0150.00%-0.0171.43%-0.04-304.88%-0.01-415.91%-0.02106.67%0.0150.00%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data